Andor Pivarcsi
Professor vid Institutionen för medicinsk biokemi och mikrobiologi; Biokemi och Cancer; Andor Pivarcsi
- E-post:
- andor.pivarcsi@imbim.uu.se
- Besöksadress:
- BMC
Husargatan 3
752 37 UPPSALA - Postadress:
- Box 582
751 23 UPPSALA
Forskare vid Institutionen för medicinska vetenskaper; Dermatologi och venereologi
- Besöksadress:
- Akademiska sjukhuset, ingång 85, 3 tr
- Postadress:
- Akademiska sjukhuset, ingång 40, 5 tr
751 85 UPPSALA
Mer information visas för dig som medarbetare om du loggar in.
Nyckelord
- cancer
- cell differentiation
- crispr
- crispr-cas9
- epigenetics
- rna interference
- transcription factor
- transcriptomics
Publikationer
Senaste publikationer
- Cutaneous squamous cell carcinoma-derived extracellular vesicles exert an oncogenic role by activating cancer-associated fibroblasts (2023)
- Long noncoding RNA plasmacytoma variant translocation 1 is overexpressed in cutaneous squamous cell carcinoma and exon 2 is critical for its oncogenicity (2023)
- The Long Noncoding RNA LINC00958 Is Induced in Psoriasis Epidermis and Modulates Epidermal Proliferation (2023)
- MicroRNA-23b Plays a Tumor-Suppressive Role in Cutaneous Squamous Cell Carcinoma and Targets Ras-Related Protein RRAS2 (2023)
- miR ‐378a regulates keratinocyte responsiveness to interleukin‐17A in psoriasis (2022)
Alla publikationer
Artiklar
- Cutaneous squamous cell carcinoma-derived extracellular vesicles exert an oncogenic role by activating cancer-associated fibroblasts (2023)
- Long noncoding RNA plasmacytoma variant translocation 1 is overexpressed in cutaneous squamous cell carcinoma and exon 2 is critical for its oncogenicity (2023)
- The Long Noncoding RNA LINC00958 Is Induced in Psoriasis Epidermis and Modulates Epidermal Proliferation (2023)
- MicroRNA-23b Plays a Tumor-Suppressive Role in Cutaneous Squamous Cell Carcinoma and Targets Ras-Related Protein RRAS2 (2023)
- miR ‐378a regulates keratinocyte responsiveness to interleukin‐17A in psoriasis (2022)
- miR-19a/b and miR-20a promote wound healing by regulating the inflammatory response of keratinocytes (2021)
- MiR-130a Acts as a Tumor Suppressor MicroRNA in Cutaneous Squamous Cell Carcinoma and Regulates the Activity of the BMP/SMAD Pathway by Suppressing ACVR1 (2021)
- Chromatin interactions in differentiating keratinocytes reveal novel atopic dermatitis- and psoriasis-associated genes (2021)
- Cross-talk between IFN-γ and TWEAK through miR-149 amplifies skin inflammation in psoriasis (2021)
- A comprehensive analysis of coding and non-coding transcriptomic changes in cutaneous squamous cell carcinoma (2020)
- EGFR/Ras-induced CCL20 production modulates the tumour microenvironment. (2020)
- Circulating microRNAs in extracellular vesicles as potential biomarkers for psoriatic arthritis in patients with psoriasis (2020)
- The Keratinocyte Transcriptome in Psoriasis (2019)
- Next-Generation Sequencing Identifies the Keratinocyte-Specific miRNA Signature of Psoriasis. (2019)
- Genome-Wide Screen for MicroRNAs Reveals a Role for miR-203 in Melanoma Metastasis. (2018)
- Identification of chronological and photoageing-associated microRNAs in human skin. (2018)
- Tofacitinib Represses the Janus Kinase-Signal Transducer and Activators of Transcription Signalling Pathway in Keratinocytes. (2018)
- Extracellular microvesicle microRNAs as predictive biomarkers for targeted therapy in metastastic cutaneous malignant melanoma. (2018)
- MicroRNA-132 with Therapeutic Potential in Chronic Wounds. (2017)
- MicroRNA-132 promotes fibroblast migration via regulating RAS p21 protein activator 1 in skin wound healing. (2017)
- MicroRNA-146a suppresses IL-17-mediated skin inflammation and is genetically associated with psoriasis. (2017)
- MicroRNA-203 Inversely Correlates with Differentiation Grade, Targets c-MYC, and Functions as a Tumor Suppressor in cSCC. (2016)
- MicroRNA-31 Promotes Skin Wound Healing by Enhancing Keratinocyte Proliferation and Migration. (2015)
- MicroRNA-132 enhances transition from inflammation to proliferation during wound healing. (2015)
- miR-193b/365a cluster controls progression of epidermal squamous cell carcinoma. (2014)
- Activation of toll-like receptors alters the microRNA expression profile of keratinocytes. (2014)
- MiR-146a negatively regulates TLR2-induced inflammatory responses in keratinocytes. (2014)
- Genetic polymorphisms altering microRNA activity in psoriasis--a key to solve the puzzle of missing heritability? (2014)
- Identification of novel non-coding RNA-based negative feedback regulating the expression of the oncogenic transcription factor GLI1. (2014)
- MicroRNA-31 is overexpressed in cutaneous squamous cell carcinoma and regulates cell motility and colony formation ability of tumor cells. (2014)
- Next-generation sequencing identifies microRNAs that associate with pathogenic autoimmune neuroinflammation in rats. (2013)
- Changes in the level of serum microRNAs in patients with psoriasis after antitumour necrosis factor-α therapy. (2013)
- RNA editing of the GLI1 transcription factor modulates the output of Hedgehog signaling. (2013)
- Are BIC (miR-155) polymorphisms associated with eczema susceptibility? (2013)
- Interleukin-8 is regulated by miR-203 at the posttranscriptional level in primary human keratinocytes. (2013)
- MicroRNA-31 is overexpressed in psoriasis and modulates inflammatory cytokine and chemokine production in keratinocytes via targeting serine/threonine kinase 40. (2013)
- Constraints for monocyte-derived dendritic cell functions under inflammatory conditions. (2012)
- MiR-21 is up-regulated in psoriasis and suppresses T cell apoptosis. (2012)
- MicroRNA-203 functions as a tumor suppressor in basal cell carcinoma. (2012)
- Characterization of EGFR and ErbB2 expression in atopic dermatitis patients. (2012)
- MicroRNA-125b down-regulates matrix metallopeptidase 13 and inhibits cutaneous squamous cell carcinoma cell proliferation, migration, and invasion. (2012)
- MicroRNAs in inflammation and response to injuries induced by environmental pollution. (2011)
- MiR-125b, a microRNA downregulated in psoriasis, modulates keratinocyte proliferation by targeting FGFR2. (2011)
- MYCN-regulated microRNAs repress estrogen receptor-alpha (ESR1) expression and neuronal differentiation in human neuroblastoma. (2010)
- MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative responses by targeting cytotoxic T lymphocyte-associated antigen 4. (2010)
- Protein kinase C-dependent upregulation of miR-203 induces the differentiation of human keratinocytes (2010)
- The expression of microRNA-203 during human skin morphogenesis. (2010)
- The human antimicrobial peptide LL-37 suppresses apoptosis in keratinocytes. (2009)
- A novel mechanism for anti-EGFR antibody action involves chemokine-mediated leukocyte infiltration. (2009)
- Advances in microRNAs (2009)
- microRNAs in inflammation. (2009)
- Human antimicrobial protein hCAP18/LL-37 promotes a metastatic phenotype in breast cancer. (2009)
- Differential expression of D-type cyclins in HaCaT keratinocytes and in psoriasis. (2008)
- MicroRNAs (2008)
- MicroRNAs and immunity (2008)
- Toll-like receptor 9-independent suppression of skin inflammation by oligonucleotides. (2007)
- Tumor immune escape by the loss of homeostatic chemokine expression. (2007)
- MicroRNAs (2007)
- Human adult epidermal melanocytes cultured without chemical mitogens express the EGF receptor and respond to EGF. (2007)
- Budesonide, but not tacrolimus, affects the immune functions of normal human keratinocytes. (2006)
- Propionibacterium acnes and lipopolysaccharide induce the expression of antimicrobial peptides and proinflammatory cytokines/chemokines in human sebocytes. (2006)
- The expression of keratinocyte growth factor receptor (FGFR2-IIIb) correlates with the high proliferative rate of HaCaT keratinocytes. (2006)
- IL-31 (2006)
- CCL1-CCR8 interactions (2005)
- Distinct strains of Propionibacterium acnes induce selective human beta-defensin-2 and interleukin-8 expression in human keratinocytes through toll-like receptors. (2005)
- Chemokine networks in atopic dermatitis (2005)
- Microbial compounds induce the expression of pro-inflammatory cytokines, chemokines and human beta-defensin-2 in vaginal epithelial cells. (2005)
- Identification and characterization of a novel, psoriasis susceptibility-related noncoding RNA gene, PRINS. (2005)
- Negative regulatory effect of histamine in DNFB-induced contact hypersensitivity. (2004)
- Innate immune functions of the keratinocytes. A review. (2004)
- CC chemokine ligand 18, an atopic dermatitis-associated and dendritic cell-derived chemokine, is regulated by staphylococcal products and allergen exposure. (2004)
- Differentiation-regulated expression of Toll-like receptors 2 and 4 in HaCaT keratinocytes. (2004)
- Proliferating keratinocytes are putative sources of the psoriasis susceptibility-related EDA+ (extra domain A of fibronectin) oncofetal fibronectin. (2004)
- The role of innate immunity in the pathogenesis of acne. (2003)
- Hemese, a hemocyte-specific transmembrane protein, affects the cellular immune response in Drosophila. (2003)
- Expression and function of Toll-like receptors 2 and 4 in human keratinocytes. (2003)
- Dithranol upregulates IL-10 receptors on the cultured human keratinocyte cell line HaCaT. (2001)
- Serum factors regulate the expression of the proliferation-related genes alpha5 integrin and keratin 1, but not keratin 10, in HaCaT keratinocytes. (2001)
- A mannose-binding receptor is expressed on human keratinocytes and mediates killing of Candida albicans. (2001)
- Histidine decarboxylase expression in human melanoma. (2000)
